A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Public ClinicalTrials.gov record NCT00293891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00293891
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 658 participants
Conditions and interventions
Conditions
Interventions
- Tacrolimus Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Dec 31, 2006
- Last update posted
- Dec 23, 2007
Ends 2007
United States locations
- U.S. sites
- 27
- U.S. states
- 22
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35205 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Denver | Colorado | 80246 | — |
| Not listed | Miami | Florida | 33144 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Newnan | Georgia | 30263 | — |
| Not listed | Indianapolis | Indiana | 46256 | — |
| Not listed | Louisville | Kentucky | 40217 | — |
| Not listed | North Andover | Massachusetts | 01845 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Port Huron | Michigan | 48060 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Omaha | Nebraska | 68144 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Columbus | Ohio | 43212 | — |
| Not listed | Dayton | Ohio | 45408 | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Knoxville | Tennessee | 37917 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Houston | Texas | 77058 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00293891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2007 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00293891 live on ClinicalTrials.gov.